Procedure: 9% sodium chloride (nacl) iv (DrugBank: Sodium chloride, Chloride)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
78 | 下垂体前葉機能低下症 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04465565 (ClinicalTrials.gov) | December 2020 | 3/7/2020 | Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test | Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test- Randomized, 2 Arms, Controlled Study | Growth Hormone Deficiency | Procedure: 9% Sodium Chloride (NaCl) IV | Rabin Medical Center | NULL | Not yet recruiting | 7 Years | 16 Years | All | 120 | N/A | Israel |